Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we will assume that you are happy to receive all cookies and you will not see this message again. Click 'Find out more' for information on how to change your cookie settings.
Cytoophidia (green) in fruitfly ovarian cells. Ji-Long Liu

Research Overview

The past decade, since the first human genome was sequenced, has witnessed an explosion of information.  Today DNA sequencing is becoming quicker and cheaper enabling the scientist to apply the fruits of their work directly to help patients.

The FGU is a leader in the analysis of genomic information and applying it to clinical problems, particularly neurological disorders such as Parkinson’s disease, muscular dystrophy, motor neuron disease, intellectual disability and schizophrenia.

We are working closely with our clinical colleagues and the major charities (Action Duchenne, Parkinson’s UK, Motor Neuron Disease Association, Muscular Dystrophy Campaign and Muscular Dystrophy Association, USA) to deliver better diagnosis and treatment for patients.